Compounds > arabinofuranosyluracil

arabinofuranosyluracil and Adenocarcinoma

arabinofuranosyluracil has been researched along with Adenocarcinoma in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (66.67)29.6817
2010's1 (33.33)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Heo, K; Kang, SH; Kim, D; Kim, EO; Kim, H; Kim, IH; Kim, KT; Kim, SK; Kim, YH; Koh, SS; Lee, SJ; Lee, SW; Lee, Y; Moon, JY; Song, MS1
Alauddin, MM; Bading, JR; Bathija, P; Conti, PS; Fissekis, JD; Koda, RT; Koszalka, GW; Shahinian, AH; Vail, A1
Blasberg, R; Burgman, P; Cai, S; Finn, R; Gelovani, J; Li, GC; Ling, CC; O'donoghue, J; Serganova, I; Wen, B; Zanzonico, P1

Other Studies

3 other study(ies) available for arabinofuranosyluracil and Adenocarcinoma

ArticleYear
Efficient targeting and tumor retardation effect of pancreatic adenocarcinoma up-regulated factor (PAUF)-specific RNA replacement in pancreatic cancer mouse model.
    Cancer letters, 2014, Mar-28, Volume: 344, Issue:2

    Topics: Adenocarcinoma; Adenoviridae; Animals; Arabinofuranosyluracil; Cell Line, Tumor; Female; Genetic Therapy; Humans; Intercellular Signaling Peptides and Proteins; Iodine Radioisotopes; Lectins; Mice; Mice, Inbred BALB C; Pancreatic Neoplasms; Random Allocation; RNA; RNA, Catalytic; Thymidine Kinase; Tomography, Emission-Computed, Single-Photon; Transgenes; Xenograft Model Antitumor Assays

2014
Pharmacokinetics of the thymidine analog 2'-fluoro-5-methyl-1-beta-D-arabinofuranosyluracil (FMAU) in tumor-bearing rats.
    Nuclear medicine and biology, 2004, Volume: 31, Issue:4

    Topics: Adenocarcinoma; Animals; Arabinofuranosyluracil; Carbon Radioisotopes; Cell Line, Tumor; Colorectal Neoplasms; DNA, Neoplasm; Female; Male; Metabolic Clearance Rate; Organ Specificity; Prostatic Neoplasms; Radionuclide Imaging; Radiopharmaceuticals; Rats; Rats, Inbred F344; Thymidine; Tissue Distribution

2004
A preclinical model for noninvasive imaging of hypoxia-induced gene expression; comparison with an exogenous marker of tumor hypoxia.
    European journal of nuclear medicine and molecular imaging, 2004, Volume: 31, Issue:11

    Topics: Adenocarcinoma; Animals; Arabinofuranosyluracil; Biomarkers, Tumor; Cell Hypoxia; Cell Line, Tumor; Disease Models, Animal; DNA-Binding Proteins; Drug Evaluation, Preclinical; Feasibility Studies; Fluorine Radioisotopes; Gene Expression Profiling; Hypoxia-Inducible Factor 1; Hypoxia-Inducible Factor 1, alpha Subunit; Iodine Radioisotopes; Misonidazole; Nuclear Proteins; Radionuclide Imaging; Radiopharmaceuticals; Rats; Thymidine Kinase; Transcription Factors; Viral Proteins

2004